These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 32712250)
1. Single-ligand dual-targeting irinotecan liposomes: Control of targeting ligand display by pH-responsive PEG-shedding strategy to enhance tumor-specific therapy and attenuate toxicity. Wang Z; Lin X; Chi D; Xu Z; Lin G; Liu H; Sun J; He Z; Wang Y Int J Pharm; 2020 Sep; 587():119680. PubMed ID: 32712250 [TBL] [Abstract][Full Text] [Related]
2. Tyrosine modified irinotecan-loaded liposomes capable of simultaneously targeting LAT1 and ATB Wang Z; Chi D; Wu X; Wang Y; Lin X; Xu Z; Liu H; Sun J; He Z; Wang Y J Control Release; 2019 Dec; 316():22-33. PubMed ID: 31676386 [TBL] [Abstract][Full Text] [Related]
3. pH-Responsive PEG-Shedding and Targeting Peptide-Modified Nanoparticles for Dual-Delivery of Irinotecan and microRNA to Enhance Tumor-Specific Therapy. Juang V; Chang CH; Wang CS; Wang HE; Lo YL Small; 2019 Dec; 15(49):e1903296. PubMed ID: 31709707 [TBL] [Abstract][Full Text] [Related]
4. PEG-coated nanoparticles detachable in acidic microenvironments for the tumor-directed delivery of chemo- and gene therapies for head and neck cancer. Lo YL; Chang CH; Wang CS; Yang MH; Lin AM; Hong CJ; Tseng WH Theranostics; 2020; 10(15):6695-6714. PubMed ID: 32550898 [No Abstract] [Full Text] [Related]
5. Transporter occluded-state conformation-induced endocytosis: Amino acid transporter ATB Luo Q; Gong P; Sun M; Kou L; Ganapathy V; Jing Y; He Z; Sun J J Control Release; 2016 Dec; 243():370-380. PubMed ID: 27810556 [TBL] [Abstract][Full Text] [Related]
6. pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment. Nunes SS; Miranda SEM; de Oliveira Silva J; Fernandes RS; de Alcântara Lemos J; de Aguiar Ferreira C; Townsend DM; Cassali GD; Oliveira MC; Branco de Barros AL Biomed Pharmacother; 2021 Dec; 144():112317. PubMed ID: 34634556 [TBL] [Abstract][Full Text] [Related]
7. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo. Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887 [TBL] [Abstract][Full Text] [Related]
8. ATB Luo Q; Yang B; Tao W; Li J; Kou L; Lian H; Che X; He Z; Sun J Biomater Sci; 2017 Jan; 5(2):295-304. PubMed ID: 27991616 [TBL] [Abstract][Full Text] [Related]
9. Dual functional octreotide-modified liposomal irinotecan leads to high therapeutic efficacy for medullary thyroid carcinoma xenografts. Iwase Y; Maitani Y Cancer Sci; 2012 Feb; 103(2):310-6. PubMed ID: 22017398 [TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of irinotecan to colon cancer cells using epidermal growth factor receptor-conjugated liposomes. Liu Y; Li X; Pen R; Zuo W; Chen Y; Sun X; Gou J; Guo Q; Wen M; Li W; Yu S; Liu H; Huang M Biomed Eng Online; 2022 Aug; 21(1):53. PubMed ID: 35918704 [TBL] [Abstract][Full Text] [Related]
11. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT. Tang J; Zhang L; Liu Y; Zhang Q; Qin Y; Yin Y; Yuan W; Yang Y; Xie Y; Zhang Z; He Q Int J Pharm; 2013 Sep; 454(1):31-40. PubMed ID: 23850793 [TBL] [Abstract][Full Text] [Related]
12. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release. Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984 [TBL] [Abstract][Full Text] [Related]
14. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530 [TBL] [Abstract][Full Text] [Related]
15. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery. Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292 [TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy. Jain S; Deore SV; Ghadi R; Chaudhari D; Kuche K; Katiyar SS Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111832. PubMed ID: 33579470 [TBL] [Abstract][Full Text] [Related]
17. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin. Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505 [TBL] [Abstract][Full Text] [Related]
18. High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer. Zhang L; Wang Y; Yang Y; Liu Y; Ruan S; Zhang Q; Tai X; Chen J; Xia T; Qiu Y; Gao H; He Q ACS Appl Mater Interfaces; 2015 May; 7(18):9691-701. PubMed ID: 25845545 [TBL] [Abstract][Full Text] [Related]
19. Stepwise targeted drug delivery to liver cancer cells for enhanced therapeutic efficacy by galactose-grafted, ultra-pH-sensitive micelles. Yan G; Wang J; Hu L; Wang X; Yang G; Fu S; Cheng X; Zhang P; Tang R Acta Biomater; 2017 Mar; 51():363-373. PubMed ID: 28087485 [TBL] [Abstract][Full Text] [Related]
20. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG. Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]